Pharmaceutical VIP: Prospects and problems

I. Gozes*, M. Fridkin, J. M. Hili, D. E. Brenneman

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

Recently, multiple receptors for vasoactive intestinal peptide (VIP) have been molecularly cloned and our understanding of VIP chemistry and mechanisms of action has been broadened. The following review outlines the physiological effects of the hormone from growth regulation, reproduction, bronchodilation, vasodilation and immune interactions to neurotrophism. VIP- based drug design and non-invasive innovative delivery modes are discussed with emphasis on tumor diagnosis and treatment, impotence treatment and neuroprotection.

Original languageEnglish
Pages (from-to)1019-1034
Number of pages16
JournalCurrent Medicinal Chemistry
Volume6
Issue number11
StatePublished - 1999

Fingerprint

Dive into the research topics of 'Pharmaceutical VIP: Prospects and problems'. Together they form a unique fingerprint.

Cite this